Stock Earnings

Question 1

What are Bicara Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Bicara Therapeutics Inc has a total asset of $509, Net loss of $-67

Question 2

What are the key financial ratios for BCAX?

Accepted Answer

Bicara Therapeutics Inc's Current ratio is 28.27, has a Net margin is 0, sales per share of $0.

Question 3

How is Bicara Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Bicara Therapeutics Inc data is not available.

Question 4

Is Bicara Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Bicara Therapeutics Inc has a net loss of $-67

Question 5

Does Bicara Therapeutics Inc have any liabilities?

Accepted Answer

yes, Bicara Therapeutics Inc has liability of 18

Question 6

How many outstanding shares for Bicara Therapeutics Inc?

Accepted Answer

Bicara Therapeutics Inc has a total outstanding shares of 54.44

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022
Revenue	0	0	0	0
Revenue Growth (YoY)	--	--	--	--
Cost of Revenue	--	--	--	--
Gross Profit	--	--	--	--
Selling, General & Admin	26	18	9	6
Research & Development	94	63	30	31
Operating Expenses	121	82	39	37
Other Non Operating Income (Expenses)	--	0	-13	0
Pretax Income	-102	-67	-51	-37
Income Tax Expense	0	0	0	0
Net Income	-102	-67	-51	-37
Net Income Growth	--	31%	38%	--
Shares Outstanding (Diluted)	54.53	16.8	51.76	51.76
Shares Change (YoY)	--	-68%	0%	--
EPS (Diluted)	-1.88	-4.04	-1	-0.73
EPS Growth	--	303%	37%	--
Free Cash Flow	-101	-74	-46	-32
Free Cash Flow Per Share	-1.85	-4.4	-0.88	-0.61
Gross Margin	--	--	--	--
Operating Margin	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%
EBITDA	-121	-82	-39	-37
EBITDA Margin	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0
EBIT	-121	-82	-39	-37
EBIT Margin	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%

Bicara Therapeutics Inc (BCAX) Price